Altman Self-Rating Mania Scale (ASRM) Calculator- Free Mania Symptom Severity Tool

By /
Altman Self-Rating Mania Scale (ASRM) Calculator – Free Mania Symptom Severity Tool | Super-Calculator.com

Altman Self-Rating Mania Scale (ASRM) Calculator

This free ASRM calculator scores five core manic symptom domains over the past 7 days — elevated mood, self-confidence, decreased sleep, pressured speech, and increased activity — displaying each score on a per-item clinical reference range bar and classifying your total score against the validated cut-off of 6 for probable hypomania or mania.

Important Medical Disclaimer

This calculator is provided for informational and educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any medical decisions. The results from this calculator should be used as a reference guide only and not as the sole basis for clinical decisions.

Rate Your Symptoms — Past 7 Days
1. Positive Mood
Elevated, expansive, or unusually good mood
NormalElevatedMarkedly Elevated
Normal mood, no change from usual
2. Self-Confidence
Level of self-esteem and sense of importance
NormalInflatedGrandiose
Typical level of confidence
3. Sleep (Decreased Need)
How much less sleep you need while still feeling rested
NormalReducedSeverely Reduced
Normal sleep requirement
4. Speech (Talkativeness)
How much more talkative or pressured your speech has been
NormalTalkativePressured
Typical amount of talking
5. Activity / Energy Level
How much more active, energetic, or driven you have been
NormalIncreasedMarkedly Increased
Typical energy and activity level
Your ASRM Results
ASRM Total Score
Sum of all 5 symptom domains
0
out of 20
0 — Normal 6 = Cut-off 11 — Mania 20
Score 0-5
No Significant Elevation
Score 6-10
Probable Hypomania
Score 11-20
Probable Mania
OK
No Significant Elevation — Your score suggests no clinically significant mood elevation. Continue your regular monitoring routine and follow your established care plan.
Your ASRM Score Breakdown by Symptom Domain
1. Positive Mood (Elevated/Expansive Mood)
0
2. Self-Confidence (Grandiosity)
0
3. Sleep (Decreased Need for Sleep)
0
4. Speech (Pressured Talkativeness)
0
5. Activity / Energy Level
0
Important Medical Disclaimer

This calculator is provided for informational and educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any medical decisions. The results from this calculator should be used as a reference guide only and not as the sole basis for clinical decisions.

About This Altman Self-Rating Mania Scale (ASRM) Calculator

This free ASRM calculator is designed for adults with a known or suspected diagnosis of bipolar disorder who want to track manic symptom severity between clinical appointments, share standardized scores with their mental health team, or identify early warning signs of impending hypomanic or manic episodes. It is equally useful for clinicians seeking a quick patient-completed screening instrument to supplement their clinical assessment.

The calculator implements the validated five-domain ASRM scoring system as described in Altman et al. (1997), rating positive mood elevation, self-confidence and grandiosity, decreased need for sleep, pressured speech and talkativeness, and increased activity and energy — each from 0 (absent or normal) to 4 (severe). The clinical cut-off of 6 is applied per the original validation study, which demonstrated sensitivity above 85% and specificity above 87% against clinician-rated diagnoses using the Young Mania Rating Scale (YMRS) as the reference standard.

The per-item reference range bar visualization for each of the five ASRM symptom domains shows at a glance not just the total score but which specific domains are most elevated, helping patients and clinicians identify the symptom cluster driving mood elevation. The color-coded green, amber, and red zones correspond to the normal, probable hypomania, and probable mania classifications derived from the ASRM total score range of 0 to 20.

Altman Self-Rating Mania Scale (ASRM): A Complete Guide to Manic Episode Assessment

The Altman Self-Rating Mania Scale (ASRM) is a validated, five-item self-report instrument designed to measure the severity of manic symptoms in individuals with bipolar disorder. Developed by Dr. Eugene Altman and colleagues, the scale enables patients to assess their own mood states between clinical visits, providing clinicians with supplementary data that enhances diagnostic accuracy and treatment monitoring. Unlike clinician-administered instruments, the ASRM empowers patients to become active participants in their own care by tracking symptom fluctuations over time.

Mania represents one of the defining features of bipolar I disorder, characterized by elevated or expansive mood, decreased need for sleep, inflated self-esteem, increased goal-directed activity, and engagement in high-risk behaviors. Recognizing and quantifying these symptoms promptly is critical, as untreated manic episodes carry significant risks including impaired occupational functioning, relationship breakdown, financial harm, and hospitalization. The ASRM provides a brief, accessible screening tool that bridges the gap between clinical appointments, allowing both patients and clinicians to detect early warning signs before episodes escalate.

ASRM Scoring Formula
Total Score = Sum of ratings across all 5 domains (0-4 each) = 0 to 20
Each of the five items is scored from 0 (absent/normal) to 4 (severe/extreme). The total score ranges from 0 to 20. A score of 6 or higher is the established clinical cut-off indicating probable hypomanic or manic episode requiring clinical evaluation.

Background and Development of the ASRM

The ASRM was developed in the early 1990s to address a recognized gap in bipolar disorder monitoring. While numerous instruments existed for assessing depression, validated self-report tools for mania were comparatively scarce. Altman and colleagues constructed the scale by identifying the five core symptom domains most reliably reported by patients and most sensitive to clinical change: elevated mood, increased self-confidence, decreased need for sleep, increased talkativeness, and increased activity or energy.

The original validation study, published in 1997 in the journal Psychiatry Research, compared ASRM scores against clinician ratings on the Young Mania Rating Scale (YMRS) in hospitalised patients with bipolar disorder. The study demonstrated strong convergent validity, with the two instruments correlating significantly (r = 0.72, p less than 0.001). The ASRM’s brevity — requiring only two to three minutes to complete — and its self-administered nature made it practical for outpatient monitoring and research applications across diverse clinical settings worldwide.

Key Point: Why Self-Rating Matters in Bipolar Disorder

A distinctive challenge in bipolar disorder management is that patients experiencing hypomanic or manic states often have limited insight into their elevated mood. The ASRM helps clinicians detect discrepancies between patient self-perception and clinical observation, which itself is diagnostically informative. When patients consistently score low despite clinical evidence of elevation, this anosognosia (lack of insight) becomes an important treatment consideration.

The Five Domains of the ASRM

Each of the five items in the ASRM corresponds to a core symptom cluster of mania or hypomania. Understanding what each domain assesses helps patients complete the scale accurately and helps clinicians interpret results in context.

1. Positive Mood (Elevated/Expansive Mood): This item assesses the degree to which the patient’s mood is elevated above their typical baseline. Scores range from 0 (normal mood) through states of occasional good mood, to persistent euphoria, to a state of extreme elation that may feel uncontrollable or disconnected from circumstances. Elevated mood in mania differs from ordinary happiness in its pervasiveness, intensity, and independence from external events.

2. Self-Confidence: Grandiosity — inflated self-esteem and an exaggerated sense of one’s own abilities, importance, or powers — is a hallmark manic symptom. This item measures the spectrum from normal confidence through increased self-assurance, to inflated self-esteem, to frank grandiosity with special powers or abilities. In severe cases, grandiosity may reach delusional intensity.

3. Sleep: Decreased need for sleep is one of the most objectively verifiable and clinically significant early warning signs of mania. This item tracks the reduction in sleep hours without corresponding fatigue. A person scoring 4 on this item may report sleeping only two to three hours per night while feeling fully rested and energised — a profoundly abnormal sleep pattern that reliably predicts escalating mania if not addressed promptly.

4. Speech: Increased talkativeness and pressure of speech reflect the neurobiological acceleration that characterises manic states. This item ranges from normal speech through more talkative than usual, to difficulty being interrupted, to continuous rapid speech that is difficult for others to follow. Pressured speech is often one of the most visible signs to observers and one of the first targets of clinical intervention.

5. Activity/Energy: Increased goal-directed activity or psychomotor agitation is another cardinal feature of mania. This item captures the subjective experience of increased energy and behavioral activation, from slightly more active than usual through marked hyperactivity to constant, driven activity with little ability to rest.

Item Scoring Structure
Each item: 0 = Normal | 1 = Slight | 2 = Moderate | 3 = Marked | 4 = Severe
Scores within each item reflect both frequency and intensity of the symptom. Patients select the description that best characterises their experience over the past week. The anchor descriptions provided for each score level are critical for standardized interpretation.

Clinical Cut-Off and Score Interpretation

The established clinical cut-off for the ASRM is a total score of 6 or above, which indicates a probable hypomanic or manic episode. This cut-off was derived from the original validation study by maximising sensitivity and specificity against clinician-rated diagnoses using the YMRS as the gold standard. At this threshold, the ASRM demonstrates sensitivity above 85% and specificity above 87% for detecting clinically significant mood elevation in validated populations.

Scores in the range of 6 to 10 typically correspond to hypomania — mood elevation that is noticeable and may impair some functioning but does not reach the severity of a full manic episode. Scores of 11 to 15 suggest moderate mania, while scores of 16 to 20 indicate severe mania. It is important to note that the ASRM is a screening and monitoring tool, not a diagnostic instrument. A score at or above the cut-off does not constitute a diagnosis; clinical evaluation remains essential for diagnosis and treatment planning.

Key Point: Score Interpretation in Context

ASRM scores must be interpreted in the context of the patient’s baseline, history, and current circumstances. Some individuals may show significant functional impairment at scores that appear moderate, while others may tolerate higher scores with less disruption. Serial monitoring over time — tracking trends rather than individual scores — often provides more clinically useful information than any single score in isolation.

Comparison with Other Mania Assessment Tools

The Young Mania Rating Scale (YMRS) remains the gold standard clinician-administered mania rating scale, containing eleven items that cover a broader range of symptom domains including disruptive or aggressive behavior, appearance, and thought content. The YMRS requires clinician training and administration time of approximately fifteen to thirty minutes. The ASRM was explicitly developed as a self-report complement to instruments like the YMRS.

The Internal State Scale (ISS) and the Bipolar Inventory of Symptoms Scale (BISS) assess both manic and depressive symptoms simultaneously, which may be advantageous for monitoring mixed states. The Mood Disorder Questionnaire (MDQ) is designed as a lifetime screener for bipolar spectrum disorder rather than a current symptom severity measure — fundamentally different in purpose from the ASRM. The ASRM tracks current symptom severity in those already known or suspected to have the condition.

Reliability and Validity Evidence

The ASRM has accumulated substantial psychometric evidence supporting its use across diverse populations and settings. The original Altman et al. (1997) validation study established strong concurrent validity against the YMRS (r = 0.72, p less than 0.001) in an inpatient sample. Subsequent studies have replicated and extended these findings in outpatient populations, community samples, and digital health applications. Internal consistency, measured by Cronbach’s alpha, consistently exceeds 0.70 in published studies. Test-retest reliability over short intervals is also well-established, supporting the scale’s use for monitoring symptom change.

Limitations of the ASRM

Despite its clinical utility, the ASRM has several important limitations. First, it depends entirely on the patient’s willingness and ability to accurately report their symptoms. During severe manic episodes, impaired insight may lead patients to underreport symptom severity, paradoxically producing lower scores at times of greater clinical concern. Second, the ASRM does not assess all manic symptoms — hypersexuality, spending behavior, flight of ideas, and delusions are not directly measured. Third, the ASRM does not differentiate between mania and hypomania on the basis of duration, functional impairment, or psychotic features.

Key Point: Anosognosia and Under-Reporting

Anosognosia — impaired awareness of one’s own illness — is particularly prevalent in mania, affecting an estimated 40-50% of individuals during acute episodes. Healthcare providers should be especially vigilant when clinical observations contradict self-report scores, as this discrepancy itself carries diagnostic and prognostic significance.

Using the ASRM for Early Warning Sign Monitoring

One of the most valuable applications of the ASRM is personalized early warning sign monitoring. By establishing a patient’s typical baseline scores during euthymia, clinicians can set personalized alert thresholds sensitive to that individual’s warning signs. In cognitive-behavioral and psychoeducational therapy for bipolar disorder, the ASRM is frequently used as a homework tool between sessions, enabling patients to identify trends and discuss coping strategies that may prevent escalation.

ASRM in Digital Health and Remote Monitoring

The ASRM has proven well-suited to digital health applications including smartphone apps, electronic health record integrations, and telepsychiatry platforms. Its brevity and self-report format mean completion in under three minutes on a mobile device, making daily or weekly tracking feasible without significant burden. Research on digital administration has generally found comparable psychometric performance to paper-based administration, with additional advantages including automated scoring, longitudinal trend displays, and threshold-triggered clinical alerts.

Integration with Treatment Planning

ASRM scores provide valuable information for treatment decision-making across the spectrum of bipolar disorder management. During acute manic episodes, rapidly rising scores signal the need for intensified monitoring and medication review. During maintenance treatment, persistently elevated subscores — particularly sleep disruption — may guide targeted interventions before full episodes develop. The ASRM is most informative when used alongside a validated depression rating scale such as the PHQ-9 or QIDS, enabling detection of mixed states and mood shifts that monitoring only one polarity would miss.

When to Seek Immediate Help

Certain ASRM score patterns and accompanying symptoms warrant urgent clinical attention. Patients and caregivers should seek immediate evaluation if elevated ASRM scores are accompanied by thoughts or plans of self-harm, psychotic symptoms such as hallucinations or delusions, behaviors posing risk to the patient or others, or complete inability to sleep for more than 48 hours. An ASRM score of 15 or above should prompt urgent psychiatric review. Patients who have previously required hospitalization during manic episodes should have individualized action plans specifying the ASRM score threshold at which they should contact their mental health team.

Frequently Asked Questions

What does the Altman Self-Rating Mania Scale (ASRM) measure?
The ASRM measures the current severity of manic symptoms across five core domains: elevated mood, self-confidence, sleep, speech, and activity/energy. Each domain is rated from 0 (absent or normal) to 4 (severe), giving a total score range of 0 to 20. The scale is completed by patients themselves over approximately two to three minutes, reflecting symptoms experienced over the past week. It is used for screening, monitoring treatment response, and detecting early warning signs of manic or hypomanic episodes in individuals with bipolar disorder.
What is the clinical cut-off score for the ASRM?
A total score of 6 or above is the established clinical cut-off indicating a probable hypomanic or manic episode requiring further clinical evaluation. This threshold was determined in the original Altman et al. (1997) validation study to maximise sensitivity and specificity against clinician-rated diagnoses. Scores below 6 suggest that significant mood elevation is unlikely, while scores at or above 6 indicate that clinical assessment is warranted. The cut-off is a guideline, not an absolute threshold, and should always be interpreted in the context of individual clinical history and presentation.
How often should I complete the ASRM?
The appropriate frequency depends on your clinical situation and your healthcare provider’s recommendations. During stable euthymic periods, weekly completion is typically sufficient to detect early mood changes. During periods of known risk — such as following sleep deprivation, significant life stressors, or seasonal transitions — more frequent monitoring every two to three days may be warranted. During active hypomanic or manic episodes or immediately following medication changes, daily monitoring enables close tracking of symptom trajectory. Always discuss your monitoring plan with your mental health team.
Can the ASRM diagnose bipolar disorder?
No. The ASRM is a symptom severity measure, not a diagnostic tool. It cannot diagnose bipolar disorder or any specific subtype. A diagnosis requires a comprehensive psychiatric evaluation that considers symptom history, duration, functional impact, exclusion of medical causes, and whether criteria for distinct manic, hypomanic, or depressive episodes are met according to DSM-5 or ICD-11 criteria. The ASRM can provide valuable supplementary information during that diagnostic process, but clinical judgement by a qualified healthcare professional is always required for diagnosis.
Why might my ASRM score be low even when I feel I am not doing well?
The ASRM specifically measures manic symptoms. If you are experiencing depressive symptoms — low mood, fatigue, reduced motivation, hopelessness — your ASRM score will naturally be low, as these symptoms are not what the scale measures. To comprehensively monitor bipolar disorder, the ASRM should be paired with a validated depression rating scale. Additionally, some individuals experience mixed states where manic and depressive symptoms co-occur; in these cases, ASRM scores may appear moderate while overall functioning is significantly impaired.
Is the ASRM validated for use in adolescents?
The ASRM was originally validated in adult populations. While it has been used in adolescent studies, some caution is warranted because developmental variations in sleep, energy, and self-confidence can complicate interpretation in younger patients. Some research suggests that the standard cut-off of 6 may be less appropriate for adolescents, and clinician-administered instruments with age-appropriate anchors may provide more accurate assessment in this population. Clinicians using the ASRM with adolescents should interpret scores in the context of developmental norms and supplement with structured clinical assessment.
Can I use the ASRM if I have not been diagnosed with bipolar disorder?
The ASRM is designed for use in individuals with known or suspected bipolar disorder. If you are experiencing symptoms that concern you and have not received a psychiatric evaluation, the most important step is to consult a healthcare professional. The ASRM score can be shared with your doctor as supplementary information, but it should not be used to self-diagnose or replace professional evaluation. Elevated ASRM scores in the absence of a bipolar disorder history can have many causes that require clinical investigation.
How does the ASRM compare to the Young Mania Rating Scale (YMRS)?
The YMRS is an eleven-item clinician-administered instrument considered the gold standard for mania assessment in research and clinical settings. It covers a broader range of symptom domains and requires trained clinician administration over fifteen to thirty minutes. The ASRM was developed as a brief self-report complement to the YMRS. The original validation study found a correlation of r = 0.72 between the two instruments. While the ASRM is more practical for frequent self-monitoring, the YMRS provides more comprehensive clinical characterisation and is preferred for formal diagnostic and research assessments.
What should I do if my ASRM score is 6 or higher?
A score of 6 or above indicates probable mood elevation that warrants clinical attention. You should contact your mental health team or healthcare provider to discuss your score and current symptoms. If you have an established care plan, follow the guidance in your crisis or early warning sign plan. Do not make significant decisions about medications, finances, or major life changes during this period. Ensure adequate sleep, avoid alcohol and stimulants, and reduce commitments where possible. If you experience rapid deterioration, thoughts of harm to yourself or others, or psychotic symptoms, seek urgent or emergency psychiatric care.
Does the ASRM detect mixed states in bipolar disorder?
The ASRM measures only the manic component of mood states. Mixed episodes — characterized by simultaneous or rapidly alternating manic and depressive symptoms — may produce moderate ASRM scores that do not fully capture clinical severity. For comprehensive monitoring of mixed states, the ASRM must be complemented by a concurrent depression measure and clinical assessment that specifically evaluates the presence of mixed features as defined by DSM-5 or ICD-11.
Is poor insight into mania a problem for ASRM accuracy?
Yes. Impaired insight — anosognosia — is common during manic episodes, with research suggesting it affects 40-50% of individuals during acute mania. Patients with poor insight may genuinely not perceive their symptoms as abnormal and therefore score lower than their clinical presentation warrants. When there is a discrepancy between low self-reported ASRM scores and clinical observations, collateral information from family members or carers becomes critical. The discrepancy itself is clinically meaningful.
How is the ASRM used in bipolar disorder clinical trials?
In clinical trials, the ASRM serves as a standardized patient-reported outcome measure for assessing treatment efficacy in reducing manic symptoms. It is used at baseline, at treatment intervals, and at endpoint to quantify symptom change. Its brevity and self-report format make it practical for large-scale trials and enable comparison of findings across studies. The ASRM is often used alongside clinician-administered instruments such as the YMRS and the Clinical Global Impression for Bipolar Disorder (CGI-BP) to provide comprehensive multi-perspective assessment of treatment response.
What are the limitations of the ASRM I should be aware of?
The ASRM has several important limitations. It does not assess all manic symptoms — including hypersexuality, spending behavior, flight of ideas, and delusions — which may cause underestimation of severity in some presentations. It relies entirely on accurate self-report, which is compromised by poor insight during mania. It cannot differentiate between mania and hypomania on its own. It was originally validated primarily in adult inpatient populations. It is a screening tool, not a diagnostic instrument, and should always be supplemented by clinical assessment.
Can sleep disturbance alone cause a high ASRM score?
The sleep item has a maximum contribution of 4 points, meaning sleep disruption alone cannot produce a score above the clinical cut-off of 6. However, sleep disturbance is often one of the earliest and most sensitive indicators of impending mania. Decreased need for sleep — characterized by sleeping less while feeling fully rested and energised rather than fatigued — is particularly significant and should prompt careful clinical evaluation even when other symptom scores are low.
How does the ASRM perform across different ethnic and cultural groups?
Cross-cultural validation studies have generally found that the five-domain structure of the ASRM is stable across diverse populations, supporting its global applicability when appropriately translated and culturally adapted. Some studies have noted differences in how specific symptoms are expressed across cultural contexts. Translation into languages other than English requires careful attention to conceptual equivalence, not just literal translation. Healthcare providers should be aware of cultural factors that may influence how patients describe and rate their symptoms.
Should I complete the ASRM based on how I feel right now or over the past week?
The standard instruction is to rate symptoms based on the past week. This timeframe is chosen to capture the typical duration and pattern of manic symptoms rather than momentary fluctuations. If your mood has fluctuated significantly over the week, consider rating based on the predominant experience. If there has been a clear recent change, some clinicians prefer ratings focused on the most recent two to three days; follow the instructions provided by your healthcare team.
Can medications affect ASRM scores?
Yes. Both prescribed medications and non-prescribed substances can affect ASRM scores. Effective mood-stabilising and antipsychotic medications should reduce ASRM scores over time if they are working. Antidepressants used without mood stabiliser coverage can trigger mood elevation reflected in rising ASRM scores. Stimulant medications, corticosteroids, thyroid preparations, and stimulant drugs of misuse may elevate scores through pharmacological effects. Always contextualise ASRM scores with information about current medications and any substance use.
Is the ASRM available in languages other than English?
Yes. The ASRM has been translated and validated in multiple languages including Spanish, Portuguese, Mandarin Chinese, Japanese, Korean, Dutch, Turkish, and others. Validated translations should be preferred over informal translations, as they ensure that the psychometric properties of the original scale are maintained through rigorous translation and back-translation processes with appropriate cultural adaptation. When using translated versions, verify that the cut-off score of 6 has been confirmed in the specific translated version.
What is the difference between hypomania and mania on the ASRM?
The ASRM does not independently distinguish between hypomania and mania — this distinction requires clinical assessment based on DSM-5 or ICD-11 criteria, which consider symptom duration, functional impairment, presence of psychotic features, and whether hospitalization is required. Generally, ASRM scores of 6-10 are more likely to correspond to hypomanic presentations, while scores of 11 and above are more likely to reflect manic episodes, but there is significant individual variation.
How should I store and share my ASRM tracking data with my healthcare team?
Consistent record-keeping significantly enhances the clinical utility of ASRM monitoring. Many patients use mood tracking apps that incorporate the ASRM and generate graphical reports suitable for sharing with clinicians. Alternatively, a simple spreadsheet or paper log recording the date, total score, and any notable events or circumstances is effective. Bringing this data to appointments enables clinicians to identify patterns, correlate score changes with life events or medication adjustments, and detect seasonal patterns.
Can the ASRM be used to monitor lithium or other mood stabiliser treatment?
Yes. The ASRM is sensitive to treatment-related change and has been used in clinical trials to evaluate the efficacy of lithium, valproate, lamotrigine, and various atypical antipsychotics in reducing manic symptoms. In routine clinical practice, tracking ASRM scores before and after medication initiation or dose adjustments provides objective evidence of treatment response. Persistently elevated scores despite adequate treatment may indicate the need for medication review, dose optimisation, or augmentation strategies.
What is rapid cycling in bipolar disorder and how does the ASRM help monitor it?
Rapid cycling is defined in DSM-5 as the occurrence of four or more distinct mood episodes within a twelve-month period. It affects approximately 10-20% of people with bipolar disorder. The ASRM, used in combination with a depression scale, provides a continuous symptom record that can help clinicians identify rapid cycling patterns that might otherwise be missed between infrequent clinic visits. Graphical displays of serial ASRM and depression scores over months can clearly reveal the cycling pattern, informing treatment decisions such as optimisation of mood stabilisers.
Are there any risks to self-monitoring with tools like the ASRM?
For most patients, regular ASRM monitoring is safe and beneficial. However, some individuals find that frequent symptom monitoring increases health anxiety or hypervigilance to normal mood fluctuations. These concerns should be discussed with your mental health team, who can help you establish a monitoring frequency and an action plan that balances awareness with wellbeing. The ASRM is most effective when used as part of a collaborative care relationship, not as a standalone anxiety-provoking self-surveillance tool.
How reliable is the ASRM compared to clinician ratings?
The ASRM demonstrates good concurrent validity with clinician-administered mania scales, with correlations in the range of 0.60-0.75 across validation studies. Internal consistency (Cronbach’s alpha typically 0.70-0.85) and test-retest reliability are well-established. However, as with all self-report instruments, accuracy depends on patient insight, literacy, and honest responding. The ASRM’s primary value is extending monitoring reach between clinical contacts and empowering patients to contribute to their own care, not replacing clinician assessment.
What resources are available if I am concerned about my ASRM score?
If you score 6 or above on the ASRM, contact your mental health team or primary care provider to discuss your results and clinical situation. If you do not currently have a mental health provider, contact your primary care physician who can refer you for specialist assessment. In situations of immediate concern, including thoughts of self-harm, contact a crisis line or go to your nearest emergency department. The International Association for Suicide Prevention (iasp.info/resources/Crisis_Centers/) maintains a directory of crisis centers worldwide. The Depression and Bipolar Support Alliance and Bipolar UK offer educational resources and peer support for individuals and families affected by bipolar disorder.

Conclusion

The Altman Self-Rating Mania Scale is a well-validated, concise, and clinically useful instrument for measuring the severity of manic symptoms in bipolar disorder. Its five-item structure, brief completion time, and strong psychometric properties make it an ideal complement to clinician assessment and a powerful tool for longitudinal symptom monitoring between clinical contacts. With a cut-off score of 6, it provides a standardized threshold for triggering clinical review, making it practically valuable in both routine care and crisis prevention contexts.

Used thoughtfully — with awareness of its limitations, combined with depression monitoring, and embedded within a collaborative care relationship — the ASRM empowers patients and clinicians alike. It transforms the abstract experience of mood fluctuation into concrete, trackable data, supporting timely intervention, personalized treatment planning, and ultimately better long-term outcomes for people living with bipolar disorder.

This calculator is intended for use by individuals with a known or suspected diagnosis of bipolar disorder, in consultation with their healthcare team. If you are concerned about your mental health, please consult a qualified healthcare professional.

Scroll to Top